Nicole Karras, M.D., is a pediatric physician who specializes in treating children diagnosed with cancer, particularly blood cancers — such as leukemias and lymphomas — that would require stem cell transplant therapy.
Dr. Karras received her medical degree at the University College Dublin School of Medicine, followed by a pediatrics residency at Tulane University School of Medicine in New Orleans. She then completed a fellowship in pediatric hematology-oncology and blood & marrow transplantation at the University of Minnesota in Minneapolis.
Prior to City of Hope, worked as a pediatric hematology-oncology hospitalist and clinical instructor at Tulane University School of Medicine.
1999 to 2004 - University College Dublin School of Medicine, Dublin, Ireland, MB, BcH, BAO (Doctor of Medicine)
1995 to 1999 - University Illinois at Urbana-Champaign, B.S. in Microbiology
2009 to 2012 - Fellow, Department of Pediatric Hematology/Oncology/Blood and Marrow Transplantation, University of Minnesota School of Medicine, Minneapolis, MN
2004 to 2007 - Resident, Department of Pediatrics, Tulane University School of Medicine, New Orleans, LA
2020-present, Associate Clinical Professor, Department of Pediatrics, City of Hope, Duarte, CA
2012-2020, Assistant Clinical Professor, Department of Pediatrics, City of Hope, Duarte, CA
2008-2009, Pediatric Hematology/Oncology Hospitalist, Tulane University School of Medicine, New Orleans, LA
2007-2008, Pediatric Hematology/Oncology Clinical Instructor,Tulane University School of Medicine, New Orleans, LA
Safety of Isavuconazonium Sulfate in Pediatrics Patients With Hematologic Malignancies and Hematopoietic Cell Transplantation With Invasive Fungal Infections: A Real World Experience. Justine Ross, Nicole Karras, Bernard Tegtmeier, Chris Yamada, Jason Chen, Weili Sun, Anna Pawlowska, Joseph Rosenthal, John Zaia, Sanjeet Dadwal. Journal of Pediatric Hematology/Oncology 2020 May: 42(4):261-265
Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicenter, retrospective, cohort study Kasiani C. Myers, Elissa Furutani, Edie Weller, Bradrod Siegele, Ashley Galvin, Valerie Arsenault, Blanche P Alter, Farid Boulad, Carlos Bueso-Ramos, Lauri Burroughs, Paul Castillo, James Connelly, Stella M. Davies, Courtney D. DiMardo, Iftikhar Hanif, Richard H. Ho, Nicole Karras Lancet Haematol (2020) e238-e246
Clinical responses and persistent BRAF V600E+ blood cells in children with LCH treated with MAPK pathway inhibition. Eckstein OS, Visser J, Rodriguez-Galindo C, Allen CE; NACHO-LIBRE Study Group. Blood. 2019 Apr 11;133(15):1691-1694
Reactivation of Human Herpesvirus 6 (HHV6) in Pediatric Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recepients AB. Pawlowska, N. Karras, L. Huaying, J. DiMundo, JC Cheng, W. Sun, S. Armenian, et.al. Biol Blood and Marrow Transplant
First pediatric experience of SL-401, a CD123-targeted therapy, in patients with blastic plasmacytoid dendritic cell neoplasm: report of three cases. Sun W, Liu H, Kim Y, Karras N, Pawlowska A, Toomey D, Kyono W, Gaynon P, Rosenthal J, Stein A J Hematol Oncol. 2018 May 2;11(1):61
HLA Haploidentical Stem Cell Transplant with Pretransplant Immunosuppression for Patients with Sickle Cell Disease. Pawlowska AB, Cheng JC, Karras NA, Sun W, Wang LD, Bell AD, Gutierrez L, Rosenthal J. Biol Blood Marrow Transplant. 2018 Jan;24(1):185-189. doi: 10.1016/j.bbmt.2017.08.039. Epub 2017 Sep 20
Ratings & Reviews
Ratings and reviews below are gathered from the Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS) survey. CG CAHPS is a standardized survey that is used to measure a patient's experience in the physician office setting. Ratings are an average of all responses to questions about a provider's care, with 5 stars being the highest.